التفاصيل البيبلوغرافية
| العنوان: |
Synthesis and Antiviral Properties against SARS-CoV-2 of Epoxybenzooxocino[4,3- b ]Pyridine Derivatives. |
| المؤلفون: |
Stalinskaya, Alena L., Martynenko, Nadezhda V., Shulgau, Zarina T., Shustov, Alexandr V., Keyer, Viktoriya V., Kulakov, Ivan V. |
| المصدر: |
Molecules; Jun2022, Vol. 27 Issue 12, p3701-N.PAG, 14p |
| مصطلحات موضوعية: |
SARS-CoV-2, DRUG development, PYRIDINE derivatives, DRUGS, COVID-19 pandemic, VIRAL replication |
| مستخلص: |
The COVID-19 pandemic is ongoing as of mid-2022 and requires the development of new therapeutic drugs, because the existing clinically approved drugs are limited. In this work, seven derivatives of epoxybenzooxocinopyridine were synthesized and tested for the ability to inhibit the replication of the SARS-CoV-2 virus in cell cultures. Among the described compounds, six were not able to suppress the SARS-CoV-2 virus' replication. One compound, which is a derivative of epoxybenzooxocinopyridine with an attached side group of 3,4-dihydroquinoxalin-2-one, demonstrated antiviral activity comparable to that of one pharmaceutical drug. The described compound is a prospective lead substance, because the half-maximal effective concentration is 2.23 μg/μL, which is within a pharmacologically achievable range. [ABSTRACT FROM AUTHOR] |
|
Copyright of Molecules is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder